Phlow supplies affordable, quality, essential medicines through U.S.-based advanced manufacturing processes.
Phlow has raised $37.0M in total funding. The most recent round was Series C. The last funding was announced in July 2025.
Phlow's investors include Align Private Capital.
Phlow is headquartered in Richmond, United States.
Phlow supplies affordable, quality, essential medicines through U.S.-based advanced manufacturing processes.
Phlow is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Phlow — Funding & Investors." VCBacked, July 22, 2025, https://www.vcbacked.co/company/phlow. Accessed August 1, 2026.
VCBacked. (2025). Phlow — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/phlow
{{cite web |title=Phlow — Funding & Investors |url=https://www.vcbacked.co/company/phlow |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated